Michael Atkins
MD
Deputy Director, Georgetown Lombardi Cancer Center
👥Biography 个人简介
Michael Atkins is a pioneer in immunotherapy for kidney cancer whose work with high-dose IL-2 established the foundation for immune-based treatment approaches. He has been an important investigator in belzutifan trials and continues to advance combination immunotherapy strategies. His career spanning three decades has shaped the evolution of RCC treatment from cytokines to modern targeted immunotherapy.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Michael Atkins 的研究动态
Follow Michael Atkins's research updates
留下邮箱，当我们发布与 Michael Atkins（Georgetown University）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment